Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.

Le Gouill, Steven

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma. [electronic resource] - The New England journal of medicine 09 2017 - 1250-1260 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1533-4406

10.1056/NEJMoa1701769 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Cisplatin--administration & dosage
Combined Modality Therapy
Cytarabine--administration & dosage
Dexamethasone--administration & dosage
Female
Hematopoietic Stem Cell Transplantation
Humans
Immunologic Factors--administration & dosage
Lymphoma, Mantle-Cell--drug therapy
Maintenance Chemotherapy
Male
Middle Aged
Proportional Hazards Models
Rituximab--administration & dosage
Survival Analysis
Transplantation, Autologous